Potential Prognostic and Predictive Role of Monocyte and Lymphocyte Counts on Presentation in Patients Diagnosed With Diffuse Large B-Cell Lymphoma

Introduction: Diffuse large B-cell lymphoma (DLBCL) is the most common subtype of non-Hodgkin’s lymphoma. Nearly 40% of patients will die of relapsed disease despite the use of rituximab plus cyclophosphamide, doxorubicin, vincristine, and prednisone (R-CHOP) chemotherapy. Many prognostic markers es...

Descripción completa

Detalles Bibliográficos
Autores principales: Kharroubi, Darine M, Nsouli, Ghazi, Haroun, Zeinab
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Cureus 2023
Materias:
Pathology
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10065310/
https://www.ncbi.nlm.nih.gov/pubmed/37009375
http://dx.doi.org/10.7759/cureus.35654

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10065310/
https://www.ncbi.nlm.nih.gov/pubmed/37009375
http://dx.doi.org/10.7759/cureus.35654

Ejemplares similares